Varlitinib in Combination With mFOLFOX6 for Advanced or Metastatic Gastric Cancer (First Line)

NCT03130790 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

52

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer

Interventions

DRUG: Varlitinib
DRUG: mFOLFOX6
DRUG: Placebo
DRUG: mFOLFOX6

Sponsor

ASLAN Pharmaceuticals